nach oben

Erschienen in:

01.10.2015

Genetic counseling content: How does it impact health behavior?

verfasst von: Kimberly M. Kelly, Lee Ellington, Nancy Schoenberg, Thomas Jackson, Stephanie Dickinson, Kyle Porter, Howard Leventhal, Michael Andrykowski

Erschienen in: Journal of Behavioral Medicine | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Women with hereditary breast-ovarian cancer face decisions about screening (transvaginal ultrasound, CA125, mammography, breast exams) and proactive (before cancer) or reactive (after cancer) surgery (oophorectomy, mastectomy). The content of genetic counseling and its relation to these key health behaviors is largely unexamined. Ashkenazi Jewish women (n = 78) were surveyed through the process of genetic testing and had audiorecorded counseling sessions available for Linguistic Inquiry and Word Count analysis. Proportions for participant and counselor cognitive and affective content during sessions were used as primary predictor variables in linear mixed models for change in intentions for screening and treatment and in self-reported screening. Cognitive and affective content were important predictors of behavior. Counselor cognitive content was associated with ovarian screening. An interaction effect also emerged for CA-125, such that counselor cognitive content plus participant cognitive content or counselor affective content were associated with more screening. Teasing out the factors in risk communication that impact decision-making are critical, and affect from a risk communicator can spur action, such as cancer screening.

Beattie, M. S., Copeland, K., Fehniger, J., Cheung, E., Joseph, G., Lee, R., et al. (2013). Genetic counseling, cancer screening, breast cancer characteristics, and general health among a diverse population of BRCA genetic testers. Journal of Health Care for the Poor and Underserved, 24, 1150–1166.CrossRefPubMed

Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., Wylie, J. E., Dutson, D., et al. (2003). Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics, Part A, 118, 201–209.CrossRef

Burke, W., Daly, M., Garber, J. E., Botkin, J. R., Kahn, M. E., Lynch, P., et al. (1997). Recommendations for follow-up care of individuals with an inherited prediposition to cancer II. BRCA1 and BRCA2. Journal of the American Medical Association, 277, 997–1003.CrossRefPubMed

Coughlin, S., King, J., Richards, T., & Ekwueme, D. (2005). Breast cancer screening and socioeconomic status—35 metropolitan areas, 2000 and 2002. Morbidity and Mortality Weekly Report, 59, 982–986.

Dorval, M., Nogues, C., Berthet, P., Chiquette, J., Gauthier-Villars, M., Lasset, C., et al. (2011). Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec. European Journal of Human Genetics, 19, 494–499.PubMedCentralCrossRefPubMed

Doughty Rice, C., Ruschman, J. G., Martin, L. J., Manders, J. B., & Miller, E. (2010). Retrospective comparison of patient outcomes after in-person and telephone results disclosure counseling for BRCA1/2 genetic testing. Familial Cancer, 9, 203–212.CrossRefPubMed

Easton, D. F., Ford, D., Bishop, T., & The Breast Cancer Linkage Consortium. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. American Journal of Human Genetics, 56, 265–271.PubMedCentralPubMed

Ellington, L., Baty, B. J., McDonald, J., Venne, V., Musters, A., Roter, D., et al. (2006). Exploring genetic counseling communication patterns: The role of teaching and counseling approaches. Journal of Genetic Counseling, 15, 179–189.CrossRefPubMed

Ellington, L., Roter, D., Dudley, W. N., Baty, B. J., Upchurch, R., Larson, S., et al. (2005). Communication analysis of BRCA1 genetic counseling. Journal of Genetic Counseling, 14, 337–386.CrossRef

Finch, A., Beiner, M., Lubinski, J., Lynch, H. T., Moller, P., Rosen, B., … &Hereditary Ovarian Cancer Clinical Study Group. (2006). Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. Journal of the American Medical Association, 296(2), 185–192.

Fitzgerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O’Neil, E., Unsal, H., … & Haber, D. A. (1996). Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. The New England Journal of Medicine, 334(3), 143–149.

Graves, K. D., Schmidt, J. E., & Andrykowski, M. A. (2005). Writing about September 11, 2001: The role of emotional intelligence and the social environment. Journal of Language and Social Psychology, 24, 285–299.

Halbert, C. H., Stopfer, J. E., McDonald, J., Weathers, B., Collier, A., Troxel, A. B., et al. (2011). Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: Does time heal women’s concerns? Journal of Clinical Oncology, 29, 4302–4306.PubMedCentralCrossRefPubMed

Hartmann, L. C., Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P. G., … & Jenkins, R. B. et al. (1999). Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New England Journal of Medicine, 340(2), 77–84.

Howard, A. F., Balneaves, L. G., & Bottorff, J. L. (2009). Women’s decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: A systematic review. Journal of Genetic Counseling, 18, 578–597.CrossRefPubMed

Johnson, J. D. (1997). Cancer-related information seeking. Creeskill, NJ: Hampton Press Inc.

Kahn, J. A., Slap, G. B., Bernstein, D. I., Tissot, A. M., Kollar, L. M., Hilliard, P. A., et al. (2007). Personal meaning of human papillomavirus and pap test results in adolescent and young adult women. Health Psychology, 26, 192–200.CrossRefPubMed

Kelly, K. M., Ellington, L., Schoenberg, N., Agarwal, P., Jackson, T., Dickinson, S., … Andrykowski, M. (2014). Linking genetic counseling content to short-term outcomes in individuals at elevated breast cancer risk. Journal of Genetic Counseling, 23, 838–848.

Kelly, K., Leventhal, H., Andrykowski, M., Toppmeyer, D., Much, J., Dermody, J., … Scwalb, M. (2004a). The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations. Journal of Genetic Counseling, 13, 237–257.CrossRefPubMed

Kelly, K. M., Leventhal, H., Marvin, M., Toppmeyer, D., Much, J., Dermody, J., et al. (2004b). Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations. Genetic Testing, 8, 139–147.CrossRefPubMed

Kinney, A. Y., Simonsen, S. E., Baty, B. J., Mandal, D., Neuhausen, S. L., Seggar, K., et al. (2006). Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred. Journal of Genetic Counseling, 15, 293–305.CrossRefPubMed

Lerman, C., Hughes, C., Croyle, R. T., Main, D., Durham, C., Snyder, C., et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine, 31, 75–80.CrossRefPubMed

Leventhal, H., Benyamini, Y., Brownlee, S., Diefenbach, M., Leventhal, E. A., & Patrick-Miller, L. (1997). Illness representation: Theoretical foundations. In J. Weinman & K. Petrie (Eds.), Perceptions of health and illness (pp. 19–45). London: Harwood.

Leventhal, H., Brisette, I., & Leventhal, E. (2003). The common-sense model of self-regulation of health and illness. In L. D. Cameron & H. Leventhal (Eds.), The self-regulation of health and illness behaviour (pp. 42–65). London: Routledge.

Loader, S., Shields, C. G., & Rowley, P. T. (2004). Impact of genetic testing for breast-ovarian cancer susceptibility. Genetic Testing, 8, 1–12.CrossRefPubMed

Lodder, L. N., Frets, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., Klijn, J. G., Seynaeve, C., et al. (2002). One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: Emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Research and Treatment, 73, 97–112.CrossRefPubMed

Mannis, G. N., Fehniger, J. E., Creasman, J. S., Jacoby, V. L., & Beattie, M. S. (2013). Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing. Journal of the American Medical Association Internal Medicine, 173, 96–103.PubMed

Mehl, M., & Pennebaker, J. (2003). The sounds of social life: A psychometric analysis of students’ daily social environments and natural conversations. Journal of Personality and Social Psychology, 84, 857–870.CrossRefPubMed

Meiser, B., Butow, P. N., Barratt, A. L., Schnieden, V., Gattas, M., Kirk, J., et al. (2001). Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Education and Counseling, 44, 215–225.CrossRefPubMed

Miller, A. B., Baines, C. J., To, T., & Wall, C. (1992). Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Canadian Medical Association Journal, 147, 1477–1488.PubMedCentralPubMed

Miller, S. M., Roussi, P., Daly, M. B., Buzaglo, J. S., Sherman, K., Godwin, A. K., et al. (2005). Enhanced counseling for women undergoing BRCA1/2 testing: Impact on subsequent decision making about risk reduction behaviors. Health Education and Behavior, 32, 654–667.CrossRefPubMed

Morgan, D., Sylvester, H., Lucas, F. L., & Miesfeldt, S. (2009). Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting. Familial Cancer, 8, 277–287.CrossRefPubMed

Morris, K. T., Johnson, N., Krasikov, N., Allen, M., & Dorsey, P. (2001). Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer. American Journal of Surgery, 181, 431–433.CrossRefPubMed

Moyer, V. A., & US Preventive Services Task Force. (2014). Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 160(4), 271–281.

National Society of Genetic Counselors. (2004). Familial Cancer Risk Counseling Association: Standard Protocol. Retrieved 12/5/2008, from www.nsgc.org

Niederhoffer, K., & Pennebaker, J. (2002). Linguistic style matching in social interaction. Journal of Language and Social Psychology, 21, 337–360.

Nystrom, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjold, B., & Rutqvist, L. E. (2002). Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet, 359, 909–919.CrossRefPubMed

Obermaier, A., Youlden, D. R., Baade, P. D., & Janda, M. (2014). The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer—A population-based data linkage study. International Journal of Cancer, 134, 2211–2222.CrossRef

Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M. M., … & Offit, K. (1996). The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature Genetics, 14, 188–190.

Olivier, R. I., Lubsen-Brandsma, M. A., Verhoef, S., & van Beurden, M. (2006). CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecologic Oncology, 100, 20–26.CrossRefPubMed

O’Neill, S. C., Valdimarsdottir, H. B., Demarco, T. A., Peshkin, B. N., Graves, K. D., Brown, K., et al. (2010). BRCA1/2 test results impact risk management attitudes, intentions, and uptake. Breast Cancer Research and Treatment, 124, 755–764.PubMedCentralCrossRefPubMed

Pennebaker, J., & Francis, M. (2001). Linguistic Inquiry and Word Count. The Second Version: SLIWC. University of Texas at Austin.

Pennebaker, J. F., Francis, M. E., & Booth, R. J. (2001). Linguistic inquiry and word count LIWC 2001. Mahway: Lawrence Erlbaum Associates.

Peshkin, B. N., Schwartz, M. D., Isaacs, C., Hughes, C., Main, D., & Lerman, C. (2002). Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiology, Biomarkers and Prevention, 11, 1115–1118.PubMed

Ray, J. A., Loescher, L. J., & Brewer, M. (2005). Risk-reduction surgery decisions in high-risk women seen for genetic counseling. Journal of Genetic Counseling, 14, 473–484.CrossRefPubMed

Saadatmand, S., Tilanus-Linthorst, M. M., Rutgers, E. J., Hoogerbrugge, N., Oosterwijk, J. C., Tollenaar, R. A., ... de Koning, H. J. (2013). Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging. Journal of the National Cancer Institute, 105, 1314–1321.

Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., et al. (2002). Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of Clinical Oncology, 20, 1260–1268.CrossRefPubMed

Schwartz, M. D., Isaacs, C., Graves, K. D., Poggi, E., Peshkin, B. N., Gell, C., et al. (2012). Long-term outcomes of BRCA1/BRCA2 testing: Risk reduction and surveillance. Cancer, 118, 510–517.PubMedCentralCrossRefPubMed

Schwartz, M. D., Kaufman, E., Peshkin, B. N., Isaacs, C., Hughes, C., DeMarco, T., et al. (2003). Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. Journal of Clinical Oncology, 21, 4034–4041.CrossRefPubMed

Schwartz, M. D., Rimer, B. K., Daly, M., Sands, C., & Lerman, C. (1999). A randomized trial of breast cancer risk counseling: The impact on self-reported mammography use. American Journal of Public Health, 89, 924–926.PubMedCentralCrossRefPubMed

Tonin, P., Weber, B., Offit, K., Couch, F., Rebbeck, T. R., Neuhausen, S., et al. (1996). Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nature Medicine, 2, 1179–1183.CrossRefPubMed

van Driel, C. M., Eltahir, Y., de Vries, J., Jaspers, J. P., Oosterwijk, J. C., Mourits, M. J., et al. (2014). Risk-reducing mastectomy in BRCA1/2 mutation carriers: Factors influencing uptake and timing. Maturitas, 77, 180–184.CrossRefPubMed

Vasen, H. F., Tesfay, E., Boonstra, H., Mourits, M. J., Rutgers, E., Verheyen, R., et al. (2005). Early detection of breast and ovarian cancer in families with BRCA mutations. European Journal of Cancer, 41, 549–554.CrossRefPubMed

Wainberg, S., & Husted, J. (2004). Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiology, Biomarkers and Prevention, 13, 1989–1995.PubMed

Titel: Genetic counseling content: How does it impact health behavior?
verfasst von: Kimberly M. Kelly
Lee Ellington
Nancy Schoenberg
Thomas Jackson
Stephanie Dickinson
Kyle Porter
Howard Leventhal
Michael Andrykowski
Publikationsdatum: 01.10.2015
Verlag: Springer US
Erschienen in: Journal of Behavioral Medicine / Ausgabe 5/2015
Print ISSN: 0160-7715
Elektronische ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-014-9613-2

Neu im Fachgebiet Psychiatrie

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2015

Perceived ambiguity as a barrier to intentions to learn genome sequencing results

Measuring health-related problem solving among African Americans with multiple chronic conditions: application of Rasch analysis

Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone

Impact of melanoma genetic test reporting on perceived control over melanoma prevention